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igher organisms have evolved unusual molecular and
genetic mechanisms to generate high affinity and
highly  specific antibodies to a seemingly infinite number of
foreign antigens (1). Even though a highly diverse germline
encoded antibody repertoire is created, most of the anti-
bodies have low affinities and the organism must find a way
to modify those antibodies so that they will bind with high
affinity and neutralize viruses and toxins. In mice and hu-
mans this is done during the course of the T dependent an-
tibody response by introducing large numbers of point mu-
tations (2) into the variable (V) region genes that encode
the antigen binding site. B cells expressing antibodies with
amino acid substitutions that result in a higher affinity are
selectively stimulated to proliferate and differentiate by an-
tigen and helper T cells and these higher affinity antibodies
come to dominate the antibody response (3–5). Somatic V
region hypermutation occurs primarily in B cells, though
there is one report of V region mutation in T cell receptors
in germinal centers (6).
Even though somatic V region mutation was the first of
the many unusual molecular events that occur during B cell
differentiation to be documented (2), and the sequences of
hundreds of antibodies that are the products of this process
have been determined, less is known about the molecular
and biochemical mechanisms responsible for V region hy-
permutation than for other processes involved in the gen-
eration of antibody diversity such as V(D)J rearrangement
and isotype switching. This is due in part to the lack of cul-
tured cell systems in which the process can be studied (7, 8).
Insights are now beginning to be gained from the study of
transfected genes in mice (9–13 and reviewed in 14–16)
and cultured cell systems that can carry out V region hy-
permutation of transfected genes have recently been re-
ported (17–20).
In this issue Tumas-Brundage and Manser (21) have re-
ported on the use of transgenic mice to examine the role of
the heavy chain promoter in the location and rate of V re-
gion hypermutation. As these authors point out, the analy-
sis of the sequences of both endogenous heavy and light
chain genes and of transgenes that have undergone somatic
mutation have led to the belief that proteins that are re-
cruited to the transcriptional apparatus are involved in V
region hypermutation (12, 22–25). The salient characteris-
tics of the mutational process (26) are: (
 
a
 
) it is due primarily
to point mutations that arise at rates that are estimated to be
10
 
2
 
5
 
 to 10
 
2
 
3
 
/base pair/generation and are 4–6 orders of
magnitude higher than the rate of mutation of housekeep-
ing genes in higher organisms. This results in the accumu-
lation of 5–15 base changes in the V regions of most anti-
bodies that have been selected for during the late primary
and secondary response. However, large numbers of muta-
tions are also seen in passenger transgenes (27) and in the 3
 
9
 
untranslated regions immediately flanking the V region
(28), so the high frequency of point mutations is not an ar-
tifact of selection. There is even a report of 40–70 point
mutations in V regions associated with 
 
d
 
 constant regions,
but these antibodies do not appear to play a role in the nor-
mal response (29); (
 
b
 
) high rates of mutation occur in al-
ready rearranged heavy and light chain variable region
genes and their immediate flanking sequences. Few muta-
tions are found 5
 
9
 
 to the promoter and the mutational pro-
cess extends 3
 
9
 
 from the promoter for 1–1.5 kb with the
maximum accumulation of mutations in the coding exon
and its immediate 3
 
9
 
 flanking region (24, 25, 28, 30–32).
The fact that the mutational process begins at the site of
initiation of transcription and extends in the direction of
transcription for a limited distance has suggested to many
that transcription is involved in V region hypermutation
(12, 22–25); (
 
c
 
) the highest frequency of somatic V region
mutations is found in centroblasts in the dark zone of the
germinal center (reviewed in reference 33). V region hy-
permutation appears to occur at about the same time or just
before isotype switching but is distinct from and does not
depend on that process (34–37). It is unclear whether so-
matic mutation is limited to one stage in B cell differentia-
tion or if it can occur at lower rates in pre-B cells or in
more differentiated plasma cells since most of the relevant
studies have used sequencing techniques that have suffi-
ciently high error rates so that mutation below a rate of
10
 
2
 
5
 
 could not be detected: (
 
d
 
) although point mutations
are found throughout the V region and its immediate
flanking sequences, there are triplets such as the AGC and
TAC and their inverted repeats, GTA and GCT that are
preferred targets for the mutational process (27, 28, 38),
and more extended versions of some of those triplets such
as a purine, a G, a pyrimidine and an A or T (RGYW)
have been recognized (27, 28, 38). These hot spots for mu-
tation are not an artifact of selection since they can be de-
duced from silent base changes and from mutations in un-
translated regions (27, 28). In addition, there appears to
have been evolutionary selection for hot spot motifs in the
complementary determining regions of the V region that
encode the contact residues with antigen (39 and reviewed
in reference 15). The mutational process results in transi-
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tions more often than transversions and appears to have a
bias for the transcribed strand (27, 28, 40).
Experiments first with light chain (reviewed in reference
14) and more recently with heavy chain (reviewed in refer-
ence 16) transgenic mice have provided additional infor-
mation that has focused attention on the interrelationship
between transcription and V region hypermutation. The
first transgenic experiments by O’Brien et al. (9) showed
that transgenes located outside of the Ig locus could un-
dergo what appeared to be the normal process of V region
hypermutation and suggested that the Ig gene and its im-
mediate flanking sequences have all of the information that
is necessary to target and regulate the process. Subsequent
studies revealed that non-Ig genes such as hemoglobin,
GPT, the neomycin resistance gene or CAT could replace
all or part of the V region and still undergo hypermutation
(41, 42), proving that the coding sequence of the light
chain V region did not contain any specific signals that tar-
geted mutation to it. This suggested that the sequences
flanking the V region were responsible for targeting and
regulating the process. The essential role of flanking cis-
acting sequences was confirmed by showing that both the
intronic and 3
 
9 
 
transcriptional enhancers of the light chain
were required for mutation (12). This requirement for these
transcriptional regulatory elements drew additional atten-
tion to the potential role of transcription in V region hy-
permutation. This was reinforced by the growing apprecia-
tion that factors such as TFIIH, that were part of the basal
transcriptional apparatus, also play a role in excision repair
in eukaryotic cells in general (43, 44). Peters and Storb (13)
provided a dramatic illustration of the importance of the
initiation of transcription in V region mutation by intro-
ducing a promoter in front of the C region, which is
thought not to undergo mutation normally, and showing
that the initiation of transcription proximal to the C region
resulted in C region mutations in transgenic mice.
In an attempt to learn more about the detailed mecha-
nisms responsible for V region mutation, Betz et al. (12)
showed that the hemoglobin promoter could be substituted
for the light chain promoter in light chain transgenes with-
out having a dramatic effect on the rate of mutation. This
was an important finding since it suggested that the light
chain promoter was not required for either B cell specific-
ity or the restriction of mutation to the Ig gene. Tumas-
Brundage and Manser (21) have investigated the role of the
promoter further using a heavy chain V region transgene
that is not active in its ectopic location (16). However, on
rare occasions the V region transgene that they have intro-
duced rearranges or undergoes gene conversion so that it is
now located in the heavy chain locus (16). B cells express-
ing this V region, now in association with the endogenous
C region, are stimulated by antigen and accessory cells to
replicate and differentiate presumably in a relatively normal
manner. Because of positive selection, there are enough of
these B cells expressing the modified transgenic V region to
be recovered as hybridomas. This system has the benefit of
allowing Tumas-Brundage and Manser, and Selsing and his
colleagues who have used a similar approach (10), to ana-
lyze the behavior of modified variable region genes that are
now in the correct chromosomal location and associated
with all of the 3
 
9
 
 elements that are normally present. In ad-
dition, the B cells expressing this transgene are in a mouse
that also has B cells expressing unmodified endogenous V
regions so that V regions under the control of variant and
wild type promoters can be compared in the same mouse.
The studies described in this paper (21) and in their previ-
ous work (16) indicate that the sequences 3
 
9
 
 to the V re-
gion are important in targeting and regulating V region hy-
permutation. This is consistent with the findings of others
that there are important regulatory sequences in the intron
between J and C (29) and associated with the C regions (19). 
Tumas-Brundage and Manser have studied transgenes
with a minimal TATA-containing heavy chain promoter
or a non-Ig promoter that is from the gene that encodes
the Ig-
 
b
 
 polypeptide (45), a part of the complex through
which membrane Ig receptors signal. This B29 promoter
lacks a TATA box but shares at least six transcriptional reg-
ulatory elements, including one for Oct 2, with the Ig pro-
moter and confers B cell specific expression, so it could re-
cruit many of the same transcriptional factors as the Ig
promoter (45). There is no evidence, however, that Ig-
 
b
 
chains undergo somatic mutation. With both the minimal
Ig and the B29 promoters, V region somatic mutation oc-
curs, though perhaps at a lower frequency (21). Tumas-
Brundage and Manser also suggest that in the studies by
Betz at al. (12) there may have been a lower frequency of
mutation in the transgenes under control of the hemoglo-
bin promoter. It may be difficult to make reliable quantita-
tive comparisons between transgenes, or even between the
transgenes and a comparable endogenous gene, because dif-
ferences in expression could result in differences in selec-
tion and mutation. In fact, differences in expression could
explain why B cells expressing the modified transgenic V
region do not participate fully in the memory response
(21). The important point is that mutation occurs in Ig
genes under the control of a variety of promoters. We can-
not be certain that a transcriptional factor, or factors, that
normally interact with the Ig promoter is not also interact-
ing with these variant promoters and recruiting some B cell
and Ig gene specific factor that is required for mutation.
Nevertheless, these studies, along with those of Betz et al.
(12), suggest that the role of the promoter is non-specific in
that transcription is required but there is not a particular
regulatory sequence in the promoter that is necessary for
mutation.
Tumas-Brundage and Manser have also placed a Drosoph-
ila intron as a spacer between the promoter and the V re-
gion exon to examine whether the 3
 
9
 
 border of mutation is
determined by its distance from the promoter. Previous
studies with endogenous V regions with different distances
between the promoter and the V region suggested that the
distance from the promoter determined the 3
 
9
 
 border of
mutation (25). Tumas-Brundage and Manser found the
highest frequency of mutations in the spacer and a some- 
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what lower frequency in its immediate 3
 
9
 
 region, which is
now the displaced coding region of V (21). These findings
confirm that mutation can occur in non-Ig sequences (41,
42) and suggest that the 3
 
9
 
 border of mutation is deter-
mined by its distance from the promoter.
The authors conclude that their results support an im-
portant role for transcription in V region hypermutation.
However, it is still not obvious how transcription actually
contributes to mutation. For example, although it is true
that TFIIH is part of both the transcriptional initiation ap-
paratus and of the apparatus that carries out nucleotide ex-
cision repair (reviewed in 43 and 44), the available evi-
dence indicates that TFIIH is lost from the transcriptional
process within 30–70 bases after initiation (44). It is possi-
ble that there is pausing of transcription at certain places in
the V region, perhaps marked by the hot spot motifs, and
that TFIIH, or a similar group of proteins, are then re-
cruited to that site and carry out a process that is error
prone because of some B cell– and Ig-specific factor (23).
However, it still seems equally possible that the high rate of
transcription is merely making the V region accessible to
other factors that are not directly connected to transcrip-
tion since a role for error prone replication has not been
ruled out. This sort of argument is reminiscent of the dis-
cussions of the role of germline transcripts of the C region
in isotype switching (46) which is still unresolved, though
recent transgenic experiments suggest splicing of the germ-
line transcript is a critical event in this process (47). It is
clear that high rates of transcription per se are not sufficient
for V region hypermutation since there is little mutation in
T independent responses even though large amounts of Ig
are produced (48).
The experiments described by Tumas-Brundage and
Manser (21) demonstrate the benefits of using an in vivo
system but also illustrate why it will be difficult to resolve
the questions that are raised if only transgenic systems are
used. These are very demanding experiments and it is vir-
tually impossible in transgenic systems to do all of the con-
trols and to examine the many different constructs that are
required to identify the essential elements in these 
 
cis
 
-acting
sequences. Nevertheless, it is just those sorts of experiments
that will be required to dissect out the role of particular 
 
cis
 
-
acting elements in transcription and mutation. This will re-
quire in vitro systems in which V region mutation occurs at
the same high rates and through the same mechanisms as in
vivo (19, 20). In the meantime, studies such as those re-
ported by Tumas-Brundage and Manser (21) are contribut-
ing important information on normal mechanisms of V re-
gion hypermutation against which all in vitro
 
 
 
systems will
have to validated.
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